Precision Medicine Partnering Agreements Analysis Report and Directory 2018-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Precision Medicine Collaboration and Licensing Deals 2018-2024" report has been added to ResearchAndMarkets.com's offering.

Fully revised and updated, the report provides details of precision medicine deals from 2018 to 2024. This report contains a comprehensive listing of 1319 precision medicine deals announced since 2018 including financial terms where available including links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the world's leading biopharma companies. The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.

The initial chapters of this report provide an orientation of precision medicine dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in precision medicine dealmaking since 2018.

Chapter 3 provides an overview of the leading precision medicine deals since 2018. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in precision medicine dealmaking with a brief summary followed by a comprehensive listing of precision medicine deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of precision medicine deals signed and announced since Jan 2018, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of precision medicine partnering deals signed and announced since Jan 2018. The chapter is organized by specific precision medicine technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in precision medicine deal making since 2018. In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key Benefits

• Understand deal trends since 2018
• Browse precision medicine collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, deal type and therapy area
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in precision medicine dealmaking

2.1. Introduction

2.2. Precision medicine deals over the years

2.3. Most active precision medicine dealmakers

2.4. Precision medicine deals by deal type

2.5. Precision medicine deals by therapy area

2.6. Precision medicine deals by industry sector

2.7. Deal terms for precision medicine deals

2.7.1 Precision medicine deals headline values

2.7.2 Precision medicine deal upfront payments

2.7.3 Precision medicine deal milestone payments

2.7.4 Precision medicine royalty rates

Chapter 3 - Leading precision medicine deals

3.1. Introduction

3.2. Top precision medicine deals by value

Chapter 4 - Most active precision medicine dealmakers

4.1. Introduction

4.2. Most active precision medicine dealmakers

4.3. Most active precision medicine deals company profiles

Chapter 5 - Precision medicine contracts dealmaking directory

5.1. Introduction

5.2. Precision medicine contracts dealmaking directory

Chapter 6 - Precision medicine dealmaking by technology type

Deal directory

• Deal directory - Precision medicine deals by company A-Z
• Deal directory - Precision medicine deals by deal type
• Deal directory - Precision medicine deals by therapy area

For more information about this report visit https://www.researchandmarkets.com/r/jd042v

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.